Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2026-03-06 @ 6:55 PM
Study NCT ID:
NCT03575702
Status:
COMPLETED
Last Update Posted:
2019-05-21
First Post:
2018-06-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder.
Sponsor:
R-Pharm
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CG04043028
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |